COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 22nd, 2018 • MorphoSys AG • Pharmaceutical preparations • New York
This COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of June 27, 2010 (the “Effective Date”) by and between XENCOR, INC., a Delaware corporation with its principal offices at 111 West Lemon Avenue, Monrovia, CA 91016 (“Xencor”), and MORPHOSYS AG, a German corporation with its principal offices at Lena-Christ-Strasse 48, 82152 Martinsried/Planegg, Germany (“MorphoSys”).
Lease Agreement concerning Semmelweisstraße 7, PlaneggMorphoSys AG • March 22nd, 2018 • Pharmaceutical preparations
MorphoSys AG (District Court of Munich, HRB 121023), Lena-Christ-Strasse 48, 82152 Martinsried / Planegg, represented by its Management Board members Dr. Simon Moroney and Jens Holstein,
AMENDED AND RESTATED RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • March 22nd, 2018 • MorphoSys AG • Pharmaceutical preparations • Pennsylvania
This Amended and Restated Research and License Agreement (“Agreement”) dated as of December 22, 2004, is by and between Centocor, Inc., a Pennsylvania corporation having its principal place of business at 200 Great Valley Parkway, Malvern, Pennsylvania, 19355 (“CENTOCOR”), and MORPHOSYS AG, a German stock corporation with its principal place of business at Lena-Christ-Str. 48, 82152 Martinsried/Planegg, Germany (together with its Affiliates, “MORPHOSYS”), and amends and restates, from and after the date hereof, the Research and License Agreement having an Effective Date of December 29, 2000, as amended by a First Amendment on February 28, 2001, and again by a Second Amendment on April 21, 2003. MORPHOSYS and CENTOCOR are each hereafter referred to individually as a “Party” and together as the “Parties”.
Dr. Elisabeth Thomassen-Wolf MorphoSys AG Manager, Alliance Management Lena- Christ-Str. 48 D-82152 Martinsried/Planegg Germany RE: October 2009 Amendments to Extended Research Licenses under the Amended and Restated Research and License Agreement...MorphoSys AG • March 22nd, 2018 • Pharmaceutical preparations
Such amendment shall be effective as of the latest date under signature of this letter. Section 3.11(b) of the Research Agreement and Section 3.10(b) of the Subscription Agreement shall be replaced in their respective entireties by the amended Section 3.11(b) and Section 3.10(b) set forth above.
CONFIDENTIALResearch and License Agreement • March 22nd, 2018 • MorphoSys AG • Pharmaceutical preparations
